Antigen-encoding circular single-stranded DNA for cancer vaccine
Authors:
- 18 February 2026
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (6) , 3503-3517
Abstract
No abstract availableKeywords
Funding Information
- Fundo para o Desenvolvimento das Ciências e da Tecnologia (FDCT 0002/2021/AKP)
- National Key Research and Development Program of China (2025YFA0923100)
- National Natural Science Foundation of China (T2596083)
This publication has 69 references indexed in Scilit:
- Investigation and Regulation of DNA Nanostructures on Activating cGAS‐STING SignalingSmall Methods, 2024
- Targeted Delivery of Circular Single‐Stranded DNA Encoding IL‐12 for the Treatment of Triple‐Negative Breast CancerAdvanced Healthcare Materials, 2024
- A comprehensive comparison of DNA and RNA vaccinesAdvanced Drug Delivery Reviews, 2024
- Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast CancerJAMA Oncology, 2023
- Cancer vaccines: Building a bridge over troubled watersCell, 2022
- Next‐Generation Vaccines: Nanoparticle‐Mediated DNA and mRNA DeliveryAdvanced Healthcare Materials, 2021
- Comparison of DNA and mRNA vaccines against cancerDrug Discovery Today, 2020
- In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesBiomaterials, 2011
- Theory and in Vivo Application of Electroporative Gene DeliveryMolecular Therapy, 2000
- Chemical Stability of Nucleic Acid–Derived DrugsJournal of Pharmaceutical Sciences, 2000